© 2002 Archives of Disease in Childhood
ORIGINAL ARTICLE
The emergence of resistant pneumococcal meningitisimplications for empiric therapy
1 Department of Immunology and Infectious Diseases, The Childrens Hospital at Westmead, PO Box 3515, Parramatta, NSW 2124, Australia
2 Department of Paediatrics and Child Health, University of Sydney, Australia
3 Institute of Clinical Pathology and Medical Research, Westmead Hospital, PO Box 533, Wentworthville, NSW 2145, Australia
Correspondence to:
Correspondence to:
A/Prof P McIntyre, National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Royal Alexandra Hospital for Children and University of Sydney, Westmead, Sydney, NSW 2145, Australia;
peterm{at}wch.edu.au
Background: Following the emergence of penicillin and cephalosporin resistant pneumococcal meningitis in the United States, inclusion of vancomycin in empiric therapy for all suspected bacterial meningitis was recommended by the American Academy of Pediatrics. Few data are available to evaluate this policy.
Aims: To examine the management and clinical course in relation to antibiotic therapy of a large unselected cohort of children with pneumococcal meningitis in a geographic area where antibiotic resistance has recently increased.
Methods: Retrospective review of all cases of pneumococcal meningitis in a defined population (Sydney, Australia), 199499.
Results: A total of 104 cases without predisposing illnesses were identified; timing of lumbar puncture (LP) was known in 103. Resistance to penicillin increased from 0 to 20% over the study period. Only 57 (55%) had an early LP (prior to parenteral antibiotics); 55 (96%) had organisms on Gram stain. Severe disease (intensive care admission or death) increased significantly from 57 cases with early LP (28%) to 33 with delayed LP (42%) to 13 with no LP (62%). Evidence of pneumococcal infection was available within 24 hours in 85% of those with delayed or no LP. Outcome was not related to empiric vancomycin use, which increased from 5% prior to 1998 to 48% in 1999.
Conclusion: LP is frequently delayed in pneumococcal meningitis. Based on disease severity, empiric vancomycin is most justified when LP is deferred. If an early LP is done, vancomycin can be withheld if Gram positive diplococci are not seen.
Keywords: Streptococcus pneumoniae; meningitis; vancomycin; lumbar puncture
Abbreviations: AAP, American Academy of Pediatrics; CSF, cerebrospinal fluid; LP, lumbar puncture; TGC, third generation cephalosporin; WBC, white blood cell; WCC, white cell count
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
McGee, L., Biek, D., Ge, Y., Klugman, M., du Plessis, M., Smith, A. M., Beall, B., Whitney, C. G., Klugman, K. P.
(2009). In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother.
53: 552-556
[Abstract] [Full Text] -
Buckingham, S. C., McCullers, J. A., Lujan-Zilbermann, J., Knapp, K. M., Orman, K. L., English, B. K.
(2006). Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis. Pediatrics
117: 1688-1694
[Abstract] [Full Text] -
McIntyre, P B, MacIntyre, C R, Gilmour, R, Wang, H
(2005). A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch. Dis. Child.
90: 391-396
[Abstract] [Full Text] -
Fernandez, A., Cabellos, C., Tubau, F., Maiques, J. M., Domenech, A., Ribes, S., Linares, J., Viladrich, P. F., Gudiol, F.
(2005). Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother
55: 78-83
[Abstract] [Full Text] -
El Bashir, H, Laundy, M, Booy, R
(2003). Diagnosis and treatment of bacterial meningitis. Arch. Dis. Child.
88: 615-620
[Abstract] [Full Text] -
Riordan, F A I, Cant, A J
(2002). When to do a lumbar puncture. Arch. Dis. Child.
87: 235-237
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



